Molecular targeting therapy with angiotensin II receptor blocker for prostatic cancer

by Hiroji Uemura, Hitoshi Ishiguro, Yoshinobu Kubota
Published 2011-12-01

Molecular targeting therapy with angiotensin II receptor blocker for prostatic cancer

by Hiroji Uemura, Hitoshi Ishiguro, Yoshinobu Kubota
Published 2011-12-01

Long-term observation of fibrillation cycle length in patients under angiotensin II receptor blocker therapy for chronic atrial fibrillation

by Jun Kishihara, Shinichi Niwano, Hiroe Niwano, Yuya Aoyama, Shoko Ishikawa, Jun Oikawa, Akira Sato, Masami Murakami, Michiro Kiryu, Tohru Izumi
Published 2012-02-01

Circumscribed ciliochoroidal effusion presenting as an acute angle closure attack

by Roslyn Kathryn Manrique Lipa, María Eugenia González Sánchez, Carlos Antonio Hijar Ordovas, Abel Rojo Aragües, Carmen Garcia Borque
Published 2017-01-01

ARB Compared with non-ARB in Preventing Cardiac Events in High Risk Hypertensive Patients: An Evidence Based Case Report

by Alvin Nursalim, Yoga Yuniadi
Published 2013-06-01

Different chronotherapeutic effects of valsartan and olmesartan in non-dipper hypertensive patients during valsartan treatment at morning

by Kentaro Ushijima, Hajime Nakashima, Tsuyoshi Shiga, Kazuhiro Harada, Shizukiyo Ishikawa, Takashi Ioka, Hitoshi Ando, Akio Fujimura
Published 2015-01-01

Clinical efficacy and safety of olmesartan/hydrochlorothiazide combination therapy in patients with essential hypertension

by Luis M Ruilope
Published 2008-12-01

Renoprotective effect of pentoxifylline in advanced chronic kidney disease

by Chih-Chin Kao
Published 2015-01-01

Indications for and utilization of angiotensin receptor II blockers in patients at high cardiovascular risk

by Farsang C
Published 2011-09-01

Angiotensin II receptor blockade is associated with preserved muscle strength in chronic hemodialysis patients

by Yu-Li Lin, Shu-Yuan Chen, Yu-Hsien Lai, Chih-Hsien Wang, Chiu-Huang Kuo, Hung-Hsiang Liou, Bang-Gee Hsu
Published 2019-02-01

Valsartan: come versatilità e tollerabilità possono contribuireal contenimento della spesa sanitaria

by Francesco Vittorio Costa
Published 2011-03-01

Ipertensione arteriosa, continuum cardiovascolare e ruolo clinico dei sartanii

by Maurizio Destro
Published 2011-03-01

TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY

by V. I. Podzolkov, A. I. Tarzimanova
Published 2015-12-01

Inhibition of Angiotensin Converting Enzyme Impairs Anti-staphylococcal Immune Function in a Preclinical Model of Implant Infection

by Rishi Trikha, Danielle Greig, Benjamin V. Kelley, Zeinab Mamouei, Troy Sekimura, Nicolas Cevallos, Thomas Olson, Ameen Chaudry, Clara Magyar, Daniel Leisman, Alexandra Stavrakis, Michael R. Yeaman, Michael R. Yeaman, Nicholas M. Bernthal
Published 2020-09-01

Multicenter trial of olmesartan. Main results

by Fail' Taipovich Ageev, Ol'ga Nikolaevna Svirida, F T Ageev, O N Svirida
Published 2011-09-01

Sudden Intraoperative Hyperkalemia during Laparoscopic Radical Nephrectomy in a Patient with Underlying Renal Insufficiency

by Sung Hoon Jung, Yun-Joung Han, Sang Ho Shin, Hyo Seon Lee, Ji Young Lee
Published 2018-11-01

Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil

by Mason
Published 2011-06-01

A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors

by Siragy H
Published 2011-05-01

Angiotensin II Inhibits Insulin Binding to Endothelial Cells

by Su-Jin Oh, Won-Chul Ha, Jee-In Lee, Tae-Seo Sohn, Ji-Hyun Kim, Jung-Min Lee, Sang-Ah Chang, Oak-Kee Hong, Hyun-Shik Son
Published 2011-06-01

Inhibitors of the renin-angiotensin system ameliorates clinical and pathological aspects of experimentally induced nephrotoxic serum nephritis

by M. E. Ougaard, H. E. Jensen, I. D. Thuen, E. G. Petersen, P. H. Kvist
Published 2018-10-01